Ioglime 2mg/500mg/15mg Tablet ER
Marketer
Syntonic Lifesciences
Salt Composition
Glimepiride (2mg) + Metformin (500mg) + Pioglitazone (15mg)
Overview Ioglime 2mg/500mg/15mg Tablet ER
Glimepiride/Metformin/Pioglitazone extended-release tablets (2mg/500mg/15mg) manage blood glucose in adults with type 2 diabetes. Used alongside diet and exercise, this combination therapy enhances insulin effectiveness, reducing blood sugar. Dosage and duration should strictly follow your physician's instructions; take with food to minimize gastric discomfort. Missed doses should be taken promptly unless nearing the next scheduled dose; never double the dose. Overdosing risks hypoglycemia. Concurrent use with other diabetes medications, alcohol, or skipped meals increases hypoglycemia risk; regular blood sugar monitoring is crucial. Common side effects include nausea, diarrhea, abdominal pain, headache, bone fractures, and respiratory infections. Pre-existing kidney, liver, or heart conditions, pregnancy, or breastfeeding require prior medical consultation. Kidney function tests are typically performed before commencing treatment. Limit alcohol consumption to mitigate potential side effects.
Uses of Ioglime 2mg/500mg/15mg Tablet ER
Managing type 2 diabetes
Major Benefits of Ioglime 2mg/500mg/15mg Tablet ER:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Ioglime 2mg/500mg/15mg Extended-Release tablet whole; do not chew, crush, or divide it. Administer this medicine with food.
Common Side effects of Ioglime 2mg/500mg/15mg Tablet ER:
- Hypoglycemia (low blood glucose level)
- Headache
- Nausea
- Diarrhea
- Dizziness
- Vomiting
- Anemia (low number of red blood cells)
- Weakness
- Sinus infection
How to use Ioglime 2mg/500mg/15mg Tablet ER:
Administer this medication precisely as your physician directs, adhering to the prescribed dosage and treatment schedule. Ingest the entire tablet whole; avoid crushing, chewing, or breaking it. Consume the Ioglime 2mg/500mg/15mg Extended-Release tablet with food.
How Ioglime 2mg/500mg/15mg Tablet ER works:
Ioglime 2mg/500mg/15mg Extended-Release tablets combine glimepiride, metformin, and pioglitazone to manage blood sugar. This triple therapy offers enhanced glycemic control when monotherapy or dual-drug regimens prove insufficient. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion to reduce blood glucose levels. Metformin, a biguanide, acts by reducing hepatic glucose production, slowing intestinal glucose absorption, and improving insulin responsiveness. Pioglitazone, a thiazolidinedione, further enhances insulin sensitivity.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent alcohol use with Ioglime 2mg/500mg/15mg ER tablets is contraindicated.
PregnancyCONSULT YOUR DOCTOR
Extended-release Ioglime tablets (2mg/500mg/15mg) may pose pregnancy risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible risks prior to prescription. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Extended-release Ioglime tablets (2mg/500mg/15mg) are likely unsuitable for use while breastfeeding. Available human data indicates potential transfer to breast milk, posing a possible risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyCAUTION
Patients with kidney impairment should use Ioglime 2mg/500mg/15mg Extended-Release tablets cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates the use of Ioglime 2mg/500mg/15mg Extended-Release tablets. Physician consultation is necessary. Regular kidney function monitoring is recommended during treatment.
LiverCAUTION
Patients with liver impairment should use Ioglime 2mg/500mg/15mg Extended-Release tablets cautiously, potentially requiring dosage modification. Severe hepatic dysfunction contraindicates the use of Ioglime 2mg/500mg/15mg Extended-Release tablets; physician consultation is advised.
What if you forget to take Ioglime 2mg/500mg/15mg Tablet ER :
Should you forget to take your Ioglime 2mg/500mg/15mg Extended-Release tablet, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual medication regimen. Avoid taking a double dose.
Facts to Know About Ioglime 2mg/500mg/15mg Tablet ER
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
3,018 People bought this recently